Takeda Industry Symposium

Out of the Trial and into the Real World: Closing the Gap in RRMM

Saturday, May 8, 2021 – 16:15-17:45 CEST

Prof. Roman Hájek
Head of the Department of Hematooncology University Hospital Ostrava University of Ostrava, Ostrava, Czech Republic

Dr Karthik Ramasamy
Associate Professor of Haematology & Consultant Haematologist,
Oxford University Hospitals NHS Trust, Royal Berkshire Hospital NHS FT Myeloma Lead, Thames Valley Cancer Alliance, UK

Prof. Evangelos Terpos
Associate Professor of Hematology, Department of Clinical Therapeutics University of Athens, School of Medicine Athens, Greece

AGENDA:

16:15-16:20 Welcome and introductions
Prof. Roman Hájek
16:20-17:00 Closing the gap: A debate on the value of RCTs and RWE
Prof. Evangelos Terpos & Dr Karthik Ramasamy

  • Clinical trials are crucial to constructing new patient care models
  • RWE drives effective clinical practice for better patient care
1700-17:20 Real-world outcomes in RRMM: Bridging the gap
Prof. Roman Hájek
17:20-17:25 Key learnings and close
All faculty
17:25-17:45 Live Q&A
All faculty

RRMM – Relapsed Refractory Multiple Myeloma
RCT – Randomized Controlled Trials
RWE – Real-world Evidence

All trademarks are the property of their respective owners. ©2021 Millennium Pharmaceuticals Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. All rights reserved.

Symposium Survey